Login / Signup

Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia.

Roland Bruno WalterFrederick R AppelbaumElihu H Estey
Published in: Leukemia (2020)
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • disease activity
  • stem cells
  • systemic lupus erythematosus
  • low dose
  • acute lymphoblastic leukemia
  • mesenchymal stem cells